Junchao Feng

Title: Junchao Feng - Innovator in Tumor Marker Research

Introduction: Junchao Feng is an inventor based in Jinan, China, who is currently associated with Shandong Xinchuang Biological Technology Co., Ltd. He is focused on the development of innovative solutions in the field of biological technology. Although he has not yet been granted any patents, his work is significant in advancing research related to tumor markers.

Latest Patent Applications: Junchao Feng's notable patent application is titled "Antigen and Antibodies Prepared Based on PADI4 Serving as Tumor Marker, and Application Thereof." This application discloses an antigen and antibodies prepared based on peptidylarginine deiminase (PADI4), which serves as a tumor marker. The antigen has an amino acid sequence shown as SEQ ID NO. 1. Specific antibodies prepared using the antigen are also detailed in the application. The protein PADI4 monoclonal antibodies include a protein PADI4 monoclonal antibody coated onto an ELISA plate and a biotin-labeled protein PADI4 monoclonal antibody. A kit prepared using these antibodies can effectively and stably determine the protein PADI4 level in human serum, showcasing broad spectrum detectability and high test repeatability.

Conclusion: Junchao Feng is making strides in the field of biological technology, particularly in tumor marker research. His innovative approach and ongoing work hold promise for future advancements in medical diagnostics.